Cart
sales@molnova.com
Ro-3201195
CAS No. 249937-52-8
Ro-3201195( —— )
Catalog No. M36218 CAS No. 249937-52-8
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 329 | In Stock |
|
| 5MG | 304 | In Stock |
|
| 10MG | 456 | In Stock |
|
| 25MG | 747 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1376 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2753 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRo-3201195
-
NoteResearch use only, not for human use.
-
Brief DescriptionRo-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
-
DescriptionRo-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number249937-52-8
-
Formula Weight371.36
-
Molecular FormulaC19H18FN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC=1N(N=CC1C(=O)C2=CC(OCC(CO)O)=CC=C2)C3=CC=C(F)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MAPK13-IN-1
MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
-
EO-1606
EO-1606 is a p38MAP kinase inhibitor with anti-inflammatory activity and may be used in studies of Alzheimer;s disease and dermatitis.
-
PAF (C16)
PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.
